Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lefer

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Journal of Molecular and Cellular Cardiology|February 1, 2020
Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATPKyriakos N Papanicolaou, Deepthi Ashok, Ting Liu, et al.
Journal of the American Heart Association|February 14, 2024
Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection FractionJake E Doiron, Zhen Li, Xiaoman Yu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 24, 2010
Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in miceRadhika H Muzumdar, Derek M Huffman, John W Calvert, et al.
JACC. Basic to Translational Science|January 17, 2025
Exercise Therapy Rescues Skeletal Muscle Dysfunction and Exercise Intolerance in Cardiometabolic HFpEFHeather Quiriarte, Robert C Noland, James E Stampley, et al.
British Journal of Pharmacology|July 10, 2024
Adjunctive therapy with an oral H<sub>2</sub>S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fractionJake E Doiron, Huijing Xia, Xiaoman Yu, et al.
Science Signaling|October 31, 2013
Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injuryZ Maggie Huang, Erhe Gao, Fabio Vasconcelos Fonseca, et al.
Journal of the American College of Cardiology|December 14, 2011
Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activationJuan P Aragón, Marah E Condit, Shashi Bhushan, et al.
Journal of the American Heart Association|February 8, 2023
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine ModelKyle B LaPenna, Zhen Li, Jake E Doiron, et al.
Circulation|February 9, 2013
H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthaseKazuhisa Kondo, Shashi Bhushan, Adrienne L King, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarctionThor Tejada, Lin Tan, Rebecca A Torres, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Journal of Molecular and Cellular Cardiology|February 1, 2020
Global knockout of ROMK potassium channel worsens cardiac ischemia-reperfusion injury but cardiomyocyte-specific knockout does not: Implications for the identity of mitoKATPKyriakos N Papanicolaou, Deepthi Ashok, Ting Liu, et al.
Journal of the American Heart Association|February 14, 2024
Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection FractionJake E Doiron, Zhen Li, Xiaoman Yu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 24, 2010
Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in miceRadhika H Muzumdar, Derek M Huffman, John W Calvert, et al.
JACC. Basic to Translational Science|January 17, 2025
Exercise Therapy Rescues Skeletal Muscle Dysfunction and Exercise Intolerance in Cardiometabolic HFpEFHeather Quiriarte, Robert C Noland, James E Stampley, et al.
British Journal of Pharmacology|July 10, 2024
Adjunctive therapy with an oral H<sub>2</sub>S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fractionJake E Doiron, Huijing Xia, Xiaoman Yu, et al.
Science Signaling|October 31, 2013
Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injuryZ Maggie Huang, Erhe Gao, Fabio Vasconcelos Fonseca, et al.
Journal of the American College of Cardiology|December 14, 2011
Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activationJuan P Aragón, Marah E Condit, Shashi Bhushan, et al.
Journal of the American Heart Association|February 8, 2023
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine ModelKyle B LaPenna, Zhen Li, Jake E Doiron, et al.
Circulation|February 9, 2013
H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthaseKazuhisa Kondo, Shashi Bhushan, Adrienne L King, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarctionThor Tejada, Lin Tan, Rebecca A Torres, et al.
Pageof 19